Downregulation of cyclin-dependent kinase inhibitor; p57kip2, is involved in the cell cycle progression of vascular smooth muscle cells

Biochemical and Biophysical Research Communications

Volumn 338, Issue 3, 2005, Pages 1661-1667

  Nakano, Noritsugu ^a   Urasawa, Kazushi ^a   Takagi, Yasushi ^a   Saito, Takahiko ^a   Kaneta, Satoshi ^a   Ishikawa, Susumu ^b   Higashi, Hideaki ^b   Tsutsui, Hiroyuki ^a   Hatakeyama, Masanori ^b   Kitabatake, Akira ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cell cycle; Neointimal hyperplasia; p57kip2; Proliferation; Vascular smooth muscle cell

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN G1; PROTEIN P57;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; DOWN REGULATION; EMBRYO; GENETIC TRANSCRIPTION; HYPERPLASIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RETINOBLASTOMA; SMOOTH MUSCLE FIBER; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL CYCLE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P57; CYCLINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MUSCLE, SMOOTH, VASCULAR; PROTEIN BINDING; RATS; RNA, MESSENGER; SERUM;

ANIMALIA;

EID: 27744443696     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.10.093     Document Type: Article

References (30)

1. R. Ross The pathogenesis of atherosclerosis; a perspective for the 1990s Nature 362 1993 801 809
2. S.M. Schwartz, D. deBlois, and E.R.M. O'brien The intima: soil for atherosclerosis and restenosis Circ. Res. 77 1995 445 465
3. A. Gittenberger-de Groot, M.C. Deruiter, M. Bergwerff, and R.E. Poelmann Smooth muscle cell origin and its relation to heterogeneity in development and disease Arterioscler. Thromb. Vasc. Biol. 19 1999 1589 1594
4. C.J. Sherr Cancer cell cycles Science 274 1996 1672 1677
5. S.P. Chellappan, A. Giordano, and P.B. Fisher Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development Curr. Top. Microbiol. Immunol. 227 1998 57 103
6. C.J. Sherr, and J.M. Roberts CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev. 13 1999 1501 1512
7. F.C. Tanner, Z.Y. Yang, E. Duckers, D. Gordon, G.J. Nabel, and E.G. Nabel Expression of cyclin-dependent kinase inhibitors in vascular disease Circ. Res. 82 1999 396 403
8. F.C. Tanner, M. Boehm, L.M. Akyurek, H. San, Z.Y. Yang, J. Tashiro, G.J. Nabel, and E.G. Nabel Differential effects of the cyclin-dependent kinase inhibitors p27(kip1), p21(cip1), and p16(ink4) on vascular smooth muscle cell proliferation Circulation 101 2000 2022 2025
9. Y. Miwa, T. Sasaguri, C. Kosaka, Y. Taba, A. Ishida, T. Abumiya, and Y. Kubohara Differentiation-inducing-factor-1, a morphogen of Dictyostelium, induces G1 arrest and differentiation of vascular smooth muscle cells Circ. Res. 86 2000 68 75
10. J. Zhang, M. Fu, X. Zhu, Y. Xiao, Y. Mou, H. Zheng, M.A. Akinbami, Q. Wang, and Y.E. Chen Peroxisome proliferator-activated receptor γ is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells J. Biol. Chem. 277 2002 11505 11512
11. kip2, exhibit skeletal abnormalities and growth retardation J. Biochem. 127 2000 73 83
12. kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors Cell 85 1996 707 720
13. S. Miyake, M. Makimura, Y. Kanegae, S. Harada, Y. Sato, K. Takamori, C. Tokuda, and I. Saito Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and cosmid bearing the full-length virus genome Proc. Natl. Acad. Sci. USA 93 1996 1320 1324
14. kip1 expression by mitogenic and hypertrophic factors: involvement of transcriptional and posttranscriptional mechanisms J. Cell Biol. 148 2000 543 556
15. T. Kamura, T. Hara, M. Matsumoto, N. Ishida, F. Okumura, S. Hatakeyama, M. Yoshida, K. Nakayama, and K.I. Nakayama Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase Nat. Cell Biol. 12 2004 1229 1235
16. kip1 Nat. Cell Biol. 4 1999 193 199
17. Skp2-dependent ubiquitylation Proc. Natl. Acad. Sci. USA 100 2003 10231 10236
18. kip2 in human T lymphocytes J. Immunol. 173 2004 2383 2391
19. kip2 results in increased apoptosis and delayed differentiation during mouse development Genes Dev. 11 1997 973 983
20. kip2 in the control of tissue growth and development Genes Dev. 12 1998 3162 3167
21. C.J. Sherr G1 phase progression: cycling on cue Cell 79 1994 551 555
22. D.O. Morgan Principles of CDK regulation Nature 374 1995 131 134
23. M.V. Frolov, and N.J. Dyson Molecular mechanisms of E2F-dependent activation and pRb-mediated repression J. Cell Sci. 117 2004 2173 2181
24. M. Classon, and N. Dyson p107 and p130: versatile proteins with interesting pockets Exp. Cell Res. 264 2001 135 147
25. kip2 cooperates with Nurr1 in developing dopamine cells Proc. Natl. Acad. Sci. USA 100 2003 15619 15624
26. kip2 J. Biol. Chem. 275 2000 18767 18776
27. M.C. Stewart, R.M. Kadlcek, P.D. Robbins, J.N. Macleod, and R.T. Ballock Expression and activity of the CDK inhibitor p57kip2 in chondrocytes undergoing hypertrophic differentiation J. Bone Miner. Res. 19 2004 123 132
28. B.L. Harvat, A. Wang, P. Seth, and A.M. Jetten Up-regulation of p27Kip1, p21WAF1/Cip1 and p16Ink4a is associated with, but not sufficient for, induction of squamous differentiation J. Cell Sci. 111 1998 1185 1196
29. P. Zhang, C. Wong, D. Liu, M. Finegold, J.W. Harper, and S.J. Elledge p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step Genes Dev. 13 1999 213 224
30. L.A. Martinetz, Y. Chen, S.M. Fisher, and C.J. Conti Coordinated changes in cell cycle machinery occur during keratinocyte terminal differentiation Oncogene 18 1999 397 406